Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
NanoViricides, Inc. NNVC
$1.17
-$0.05 (-4.18%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
14078350.00000000
-
week52high
3.88
-
week52low
1.04
-
Revenue
0
-
P/E TTM
-2
-
Beta
1.07404800
-
EPS
-0.58000000
-
Last Dividend
0.00000000
-
Next Earnings Date
16 ноя 2020 г. в 21:00
Описание компании
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Diwan Anil | D | 0 | 94471 | 08 авг 2022 г. |
| BONIUK MILTON | A | 6862648 | 5500000 | 21 мая 2018 г. |
| BONIUK MILTON | A | 337500 | 150000 | 21 мая 2018 г. |
| BONIUK MILTON | A | 1362648 | 120744 | 11 июл 2017 г. |
| BONIUK MILTON | A | 1241904 | 149478 | 04 мая 2017 г. |
| BONIUK MILTON | A | 2776793 | 1746288 | 21 февр 2017 г. |
| BONIUK MILTON | A | 1092426 | 153611 | 21 февр 2017 г. |
| BONIUK MILTON | D | 0 | 1 | 01 февр 2017 г. |
| BONIUK MILTON | D | 0 | 1 | 01 февр 2017 г. |
| BONIUK MILTON | A | 1240063 | 25000 | 19 мая 2016 г. |
Новостная лента
NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City
GlobeNewsWire
04 мая 2023 г. в 06:45
SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- NanoViricides, Inc. (NYSE American: NNVC ) (the “Company”), a clinical stage global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announces that Anil R. Diwan, Ph.D., President of the Company will be presenting at The Inaugural EF Hutton Global Conference, which will be held on May 10-11, 2023, at the Plaza Hotel in the heart of New York City. NanoViricides is presenting on May 10th.
NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT
Accesswire
04 янв 2023 г. в 06:35
SHELTON, CT / ACCESSWIRE / January 4, 2023 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), announces that the Company's President, Dr. Anil Diwan, will be presenting a talk in person at the Biotech Showcase™ 2023 Conference in San Fransisco on Monday, January 9th at 10:30pm PT.
7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.
InvestorPlace
28 окт 2022 г. в 14:49
Risk is part of investing. Even the most mature, well-established firms and stocks run the risk of declining to zero.
10 Top Monkeypox Stocks To Watch Right Now
PennyStocks
04 авг 2022 г. в 14:27
10 monkeypox stocks and monkeypox penny stocks to watch The post 10 Top Monkeypox Stocks To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
NanoViricides Starts Drug Development Program For Recent Cases Of Unexplained Pediatric Hepatitis
Benzinga
16 мая 2022 г. в 12:26
NanoViricides Inc (NYSE: NNVC) has initiated a program to screen its library of broad-spectrum antiviral nanoviricides against human Adenovirus 41 Type F (hAd41-F), believed to be strongly associated with the occurrence of severe hepatitis syndrome in some children. The company says.